SRN 011
Alternative Names: SRN-011Latest Information Update: 04 Sep 2023
At a glance
- Originator siRNAgen Therapeutics
- Class Skin disorder therapies; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Skin disorders
Most Recent Events
- 23 Aug 2023 Early research in Skin disorders in South Korea (Parenteral) before August 2023 (siRNAgen Therapeutics pipeline, August 2023)